PHASE II STUDY OF COMBINATION CHEMOTHERAPY WITH ORAL S-1 AND OXALIPLATIN (SOX) IN PATIENTS WITH MUCINOUS ADENOCARCINOMA OF THE OVARY

被引：0
|
作者：
Nishio, S. [1 ]
Shimada, M. [2 ]
Kamura, T. [1 ]
Ishitani, K. [3 ]
Ochiai, K. [4 ]
Takeshima, N. [5 ]
Yokoyama, Y. [6 ]
Furumoto, H. [7 ]
Sugiyama, T. [8 ]
Kigawa, J. [2 ]
机构：
[1] Kurume Univ, Sch Med, Kurume, Fukuoka 830, Japan
[2] Tottori Univ, Yonago, Tottori, Japan
[3] Tokyo Womens Med Univ, Tokyo, Japan
[4] Jikei Univ, Sch Med, Tokyo, Japan
[5] Canc Inst Hosp, Tokyo, Japan
[6] Hirosaki Univ, Grad Sch Med, Hirosaki, Aomori, Japan
[7] Univ Tokushima, Grad Sch, Tokushima, Japan
[8] Iwate Med Univ, Sch Med, Morioka, Iwate 020, Japan
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：326 / 326
页数：1
相关论文
共 50 条
  • [41] Phase II study of gemcitabine and S-1 combination chemotherapy in patients with metastatic biliary tract cancer
    Hyeong Su Kim
    Ho Young Kim
    Dae Young Zang
    Ho Suk Oh
    Jang Yong Jeon
    Ji Woong Cho
    Choong Kee Park
    Jong Hyeok Kim
    Min-Jeong Kim
    Hong Il Ha
    Jung Han Kim
    Boram Han
    Hunho Song
    Jung Hye Kwon
    Dae Ro Choi
    Joo Young Jung
    Cancer Chemotherapy and Pharmacology, 2015, 75 : 711 - 718
  • [42] Phase II study of gemcitabine and S-1 combination chemotherapy in patients with metastatic biliary tract cancer
    Kim, Hyeong Su
    Kim, Ho Young
    Zang, Dae Young
    Oh, Ho Suk
    Jeon, Jang Yong
    Cho, Ji Woong
    Park, Choong Kee
    Kim, Jong Hyeok
    Kim, Min-Jeong
    Ha, Hong Il
    Kim, Jung Han
    Han, Boram
    Song, Hunho
    Kwon, Jung Hye
    Choi, Dae Ro
    Jung, Joo Young
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 75 (04) : 711 - 718
  • [43] A multicenter phase II study of gemcitabine and S-1 combination chemotherapy in patients with unresectable pancreatic cancer
    Oh, Do-Youn
    Cha, Yongjun
    Choi, In-Sil
    Yoon, So-Young
    Choi, In Keun
    Kim, Jee Hyun
    Oh, Sang Cheul
    Kim, Chang Duck
    Kim, Jae Sun
    Bang, Yung-Jue
    Kim, Yeul Hong
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 65 (03) : 527 - 536
  • [44] Phase II study of S-1 and oxaliplatin as neoadjuvant chemotherapy for locally advanced adenocarcinoma of the gastric or esophagogastric junction: KSCC1601
    Iwatsuki, Masaaki
    Orita, Hiroyuki
    Kobayashi, Kazuma
    Hidaka, Shigekazu
    Arigami, Takaaki
    Kusumoto, Tetsuya
    Satake, Hironaga
    Oki, Eiji
    Tsutsumi, Satoshi
    Tobimatsu, Kazutoshi
    Shimokawa, Mototsugu
    Saeki, Hiroshi
    Makiyama, Akitaka
    Baba, Hideo
    Mori, Masaki
    GASTRIC CANCER, 2022, 25 (01) : 180 - 187
  • [45] Phase II study of S-1 and oxaliplatin as neoadjuvant chemotherapy for locally advanced adenocarcinoma of the gastric or esophagogastric junction: KSCC1601
    Masaaki Iwatsuki
    Hiroyuki Orita
    Kazuma Kobayashi
    Shigekazu Hidaka
    Takaaki Arigami
    Tetsuya Kusumoto
    Hironaga Satake
    Eiji Oki
    Satoshi Tsutsumi
    Kazutoshi Tobimatsu
    Mototsugu Shimokawa
    Hiroshi Saeki
    Akitaka Makiyama
    Hideo Baba
    Masaki Mori
    Gastric Cancer, 2022, 25 : 180 - 187
  • [46] A randomized phase III study of sox (S-1/oxaliplatin) versus COX (capecitabine/oxaliplatin) in patients with advanced colorectal cancer
    Park, Y. S.
    Lim, H. Y.
    Lee, J.
    Kim, T. W.
    Lee, J.
    Hong, Y. S.
    Kim, S. Y.
    Baek, J. Y.
    Kim, J. H.
    Lee, K.
    Chung, I.
    Cho, S.
    Lee, K. H.
    Shin, S. J.
    Kang, H. J.
    Shin, D.
    Jo, S. J.
    Lee, J. W.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [47] Impact of Chemotherapy with S-1 and Oxaliplatin (SOX) in Combination with Molecular-targeting Agents on Colorectal Liver Metastases
    Watanabe, Kazuhiro
    Kawahara, Hidejiro
    Enomoto, Hiroya
    Toyama, Yoichi
    Akiba, Tadashi
    Yanaga, Katsuhiko
    ANTICANCER RESEARCH, 2013, 33 (09) : 3941 - 3946
  • [48] A phase II study of gemcitabine in combination with oxaliplatin as first line chemotherapy in patients with inoperable biliary tract adenocarcinoma
    Kim, H.
    Lee, S.
    Bae, S.
    Kim, C.
    Lee, N.
    Lee, K.
    Park, S.
    Won, J.
    Hong, D.
    Park, H.
    EJC SUPPLEMENTS, 2007, 5 (04): : 277 - 277
  • [49] Phase II study of oxaliplatin combined with S-1 (SOX) as first-line therapy for patients with advanced gastric cancer (AGC)
    Takiuchi, H.
    Koizumi, W.
    Yamada, Y.
    Boku, N.
    Komatsu, Y.
    Fuse, N.
    Muro, K.
    Tsuburaya, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [50] A phase II study of capecitabine and oxaliplatin combination chemotherapy in patients with inoperable adenocarcinoma of the gall bladder or biliary tract
    Graham J.S.
    Boyd K.
    Coxon F.Y.
    Wall L.R.
    Eatock M.M.
    Maughan T.S.
    Highley M.
    Soulis E.
    Harden S.
    Bützberger-Zimmerli P.
    Evans T.R.J.
    BMC Research Notes, 9 (1)
12345